Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04682405
What this trial is testing

Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 51
Testing effectiveness (Phase 2)Looking for participantsNCT06196255
What this trial is testing

Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 20
Large-scale testing (Phase 3)Looking for participantsNCT07648264
What this trial is testing

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Who this might be right for
Secondary Immune Deficiency
CSL Behring 63
Not applicableEnded earlyNCT03473496
What this trial is testing

CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma(MM)
Zhujiang Hospital 2
Testing effectiveness (Phase 2)UnknownNCT05298683
What this trial is testing

Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Who this might be right for
Multiple MyelomaRenal ImpairmentNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 108
Testing effectiveness (Phase 2)Looking for participantsNCT06974786
What this trial is testing

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly DiagnosedMultiple Myeloma (MM)
SCRI Development Innovations, LLC 100
Not applicableLooking for participantsNCT06767254
What this trial is testing

A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence

Who this might be right for
Multiple Myeloma (MM)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771361
What this trial is testing

BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedMultiple Myeloma RefractoryMultiple Myeloma in Relapse+5 more
Luminary Therapeutics 90
Testing effectiveness (Phase 2)Looking for participantsNCT06518551
What this trial is testing

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

Who this might be right for
MyelomaMultiple MyelomaRefractory Multiple Myeloma
Omar Nadeem, MD 49
Testing effectiveness (Phase 2)UnknownNCT00526734
What this trial is testing

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Erasme University Hospital 100
Very early researchLooking for participantsNCT07429721
What this trial is testing

A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma (MM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Not applicableStudy completedNCT06838065
What this trial is testing

Rehabilitation Management for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma Bone LesionsMultiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 128
Very early researchNot Yet RecruitingNCT07628595
What this trial is testing

Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
The First Affiliated Hospital with Nanjing Medical University 19
Testing effectiveness (Phase 2)Study completedNCT01946477
What this trial is testing

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

Who this might be right for
Multiple Myeloma
Celgene 186
Early research (Phase 1)Ended earlyNCT01985477
What this trial is testing

Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 2
Not applicableUnknownNCT01314625
What this trial is testing

A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Testing effectiveness (Phase 2)Ended earlyNCT00293111
What this trial is testing

Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Cephalon 30
Not applicableStudy completedNCT04721002
What this trial is testing

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma (MM)
AbbVie 514
Large-scale testing (Phase 3)UnknownNCT06324266
What this trial is testing

Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation

Who this might be right for
Newly Diagnosed Multiple Myeloma
Jinling Hospital, China 80
Not applicableLooking for participantsNCT06871176
What this trial is testing

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 30
Next Page